REGULATORY WORKSHOP ON THE DEVELOPMENT OF CAR-T CELLS

The workshop is jointly organized by the EU-funded projects EURE-CART and CARAMBA and will be run-up to the 2nd European CAR T Cell Meeting. Its aim is to share and discuss regulatory experiences during the development of CAR-T cells. Target audience for the workshop are hematologists, oncologists, physicians, nurses, data managers, and patient organization representatives. The participant number is limited to 100 participants.

Health

30 Janvier 2020 - 30 Janvier 2020

Sitges, Spain

First approvals of the CAR T cell treatments in Europe present a great opportunity to fight hematological malignancies. However, the route from bench to bedside poses several challenges, demanding for a European-wide harmonization process. During the workshop the projects EURE-CART (www.eure-cart.eu) and CARAMBA (www.caramba-cart.eu) will present their current regulatory experiences and discuss those with representatives of national regulatory authorities. It is a great opportunity to analyze the lessons learnt and to define future perspectives on how to accelerate the treatment with CAR-T cells.

https://www.caramba-cart.eu/eure-cart-caramba-joint-open-regulatory-workshop/

Mots‑clés

CAR-T, regulatory, ATMP

REGULATORY WORKSHOP ON THE DEVELOPMENT OF CAR-T CELLS

Mots‑clés

Partager cette page Partager cette page sur les réseaux sociaux

Télécharger Télécharger le contenu de la page